125 related articles for article (PubMed ID: 16824084)
1. Treatment of acute hepatitis C in a child with thalassemia major using weight-based peginterferon alpha-2b.
Sharara AI; Aoun E; Koussa S; Inati A; Taher A
J Gastroenterol Hepatol; 2006 Jul; 21(7):1221. PubMed ID: 16824084
[No Abstract] [Full Text] [Related]
2. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.
Malnick SD; Basevitch A
Gastroenterology; 2006 Aug; 131(2):683; author reply 683-4. PubMed ID: 16890628
[No Abstract] [Full Text] [Related]
3. Peginterferon alfa-2b vs. peginterferon alfa-2a in the treatment of hepatitis C, is there any difference?
Sierra F
J Hepatol; 2007 Feb; 46(2):349; author reply 349-50. PubMed ID: 17161495
[No Abstract] [Full Text] [Related]
4. Treatment of acute hepatitis C-how to explain the differences?
Wedemeyer H; Cornberg M; Wiegand J; Jäckel E; Manns MP
Gastroenterology; 2006 Aug; 131(2):682-3; author reply 683-4. PubMed ID: 16890627
[No Abstract] [Full Text] [Related]
5. Pegylated interferon alpha-2b in patients with acute hepatitis C.
Mukhopadhyay A
Natl Med J India; 2006; 19(4):201-2. PubMed ID: 17100108
[No Abstract] [Full Text] [Related]
6. Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin.
Buti M; Sanchez-Avila F; Lurie Y; Stalgis C; Valdés A; Martell M; Esteban R
Hepatology; 2002 Apr; 35(4):930-6. PubMed ID: 11915041
[TBL] [Abstract][Full Text] [Related]
7. Peginterferon alfa-2b treatment for patients affected by acute hepatitis C: presentation of six case reports.
Scotto G; Palumbo E; Fazio V; Cibelli DC; Saracino A; Angarano G
Infection; 2005 Feb; 33(1):30-2. PubMed ID: 15750757
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute hepatitis C with interferon alfa-2b.
Patel R; Germer JJ
N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11932480
[No Abstract] [Full Text] [Related]
9. Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferon.
Herrmann E; Lee JH; Marinos G; Modi M; Zeuzem S
Hepatology; 2003 Jun; 37(6):1351-8. PubMed ID: 12774014
[TBL] [Abstract][Full Text] [Related]
10. Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.
Lukasiewicz E; Hellstrand K; Westin J; Ferrari C; Neumann AU; Pawlotsky JM; Schalm SW; Zeuzem S; Veldt BJ; Hansen BE; Verhey-Hart E; Lagging M
Hepatology; 2007 Jan; 45(1):258-9. PubMed ID: 17187414
[No Abstract] [Full Text] [Related]
11. Treatment of hepatitis C: don't put all your eggs in one basket!
Pawlotsky JM
Gastroenterology; 2007 Apr; 132(4):1611-5. PubMed ID: 17418174
[No Abstract] [Full Text] [Related]
12. HCV findings presented at EASL: long-term follow-up and the criteria of a cure.
Lang L
Gastroenterology; 2007 Jun; 132(7):2282-3. PubMed ID: 17570197
[No Abstract] [Full Text] [Related]
13. Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b.
Venezia G; Licata A; Di Marco V; Craxì A; Almasio PL
Dig Liver Dis; 2005 Nov; 37(11):882-5. PubMed ID: 16169301
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.
Castells L; Vargas V; Allende H; Bilbao I; Luis Lázaro J; Margarit C; Esteban R; Guardia J
J Hepatol; 2005 Jul; 43(1):53-9. PubMed ID: 15876467
[TBL] [Abstract][Full Text] [Related]
15. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
[TBL] [Abstract][Full Text] [Related]
16. Delaying HCV treatment in HIV-positive patients.
Carter M
IAPAC Mon; 2005 May; 11(5):147. PubMed ID: 16201045
[No Abstract] [Full Text] [Related]
17. Peginterferon alfa-2b and ribavirin in thalassaemia/chronic hepatitis C virus-co-infected non-responder to standard interferon-based.
Hamidah A; Thambidorai CR; Jamal R
Med J Malaysia; 2005 Oct; 60(4):517-9. PubMed ID: 16570722
[TBL] [Abstract][Full Text] [Related]
18. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.
Wiegand J; Cornberg M; Aslan N; Schlaphoff V; Sarrazin C; Kubitschke A; Buggisch P; Ciner A; Jaeckel E; Manns MP; Wedemeyer H
Antivir Ther; 2007; 12(3):303-16. PubMed ID: 17591020
[TBL] [Abstract][Full Text] [Related]
19. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.
Kamal SM; Fouly AE; Kamel RR; Hockenjos B; Al Tawil A; Khalifa KE; He Q; Koziel MJ; El Naggar KM; Rasenack J; Afdhal NH
Gastroenterology; 2006 Mar; 130(3):632-8. PubMed ID: 16530503
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of hepatitis C virus infection].
Zeuzem S
Praxis (Bern 1994); 2005 May; 94(18):721-6. PubMed ID: 15938383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
